Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

596
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
596
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

72
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
72
Time Course of Drug Effect01:14

Time Course of Drug Effect

2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Steady State Concentration01:05

Steady State Concentration

4.3K
A steady state refers to the level of a drug in the body once it has reached an equilibrium between administration and elimination. It represents the point at which the drug administration rate equals the drug elimination rate, resulting in a relatively constant concentration in the body over time. The dynamic equilibrium is crucial to ensure the drug's effectiveness with minimal risk of toxicity.
Most drugs are administered in repeated doses at fixed intervals or through continuous...
4.3K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
104
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

347
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
347

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Generalizability in Whole-Cell Antibiotic Discovery Through Active Learning.

bioRxiv : the preprint server for biology·2026
Same author

Long-Term Outcomes of Sacral Neuromodulation Explantation: A 12-Year Experience at a High-Volume Tertiary Center.

Neurourology and urodynamics·2026
Same author

Real-World Long-Term Outcomes of Rezūm Therapy for Large-Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study.

Lower urinary tract symptoms·2026
Same author

Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study.

Cancer research communications·2026
Same author

Predictors of surgical retreatment following Rezūm water vapor therapy: a multi-center real-world cohort study.

World journal of urology·2026
Same author

Oncological Outcomes of Nonmuscle-Invasive Bladder Cancer in Patients Aged 45 Years and Younger: A Retrospective Matched Cohort Study.

The Journal of urology·2026

Related Experiment Video

Updated: Jun 14, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Statin Concentration in Prostatic Tissue is Subtype- and Dose-dependent.

Julian Chavarriaga1, Linda Z Penn2, Najia Khurram3

  • 1Division of Urology, Department of Surgical Oncology, University Health Network & University of Toronto, Toronto, ON, Canada; Cancer Treatment and Research Centre (CTIC) Luis Carlos Sarmiento Angulo Foundation, Bogota, Colombia.

Urology
|September 2, 2024
PubMed
Summary
This summary is machine-generated.

Hydrophilic statins like rosuvastatin achieve higher prostate tissue concentrations than lipophilic statins such as atorvastatin. Statin levels in prostate tissue are dose-dependent, with measurable amounts found in patients with prostate cancer.

More Related Videos

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

3.5K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

Related Experiment Videos

Last Updated: Jun 14, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

3.5K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

Area of Science:

  • Pharmacology
  • Oncology
  • Medicinal Chemistry

Background:

  • Statins are widely prescribed for cholesterol management.
  • Understanding tissue-specific statin distribution is crucial for therapeutic optimization.
  • Lipophilic and hydrophilic statins exhibit different pharmacokinetic properties.

Purpose of the Study:

  • To compare serum and prostate tissue concentrations of lipophilic and hydrophilic statins.
  • To investigate the dose-dependency of statin concentrations in prostate tissue.
  • To provide the first comparative analysis of statin concentrations in prostate tissue.

Main Methods:

  • Retrospective analysis of 80 patients undergoing radical prostatectomy.
  • Selection of patients on atorvastatin (lipophilic) or rosuvastatin (hydrophilic).
  • Quantification of serum and prostate tissue statin concentrations using HPLC-mass spectrometry.

Main Results:

  • Rosuvastatin (hydrophilic) showed significantly higher median prostate tissue concentration (3.98 ng/g) compared to atorvastatin (lipophilic) (0.96 ng/g).
  • Measurable statin concentrations were found in 53.6% of patients taking rosuvastatin versus 38.4% taking atorvastatin.
  • A clear dose-dependency was observed for rosuvastatin, with higher concentrations at high doses (5.21 ng/g) versus low doses (1.99 ng/g).

Conclusions:

  • Lipophilic and hydrophilic statins can be measured in prostate cancer tissue.
  • Statin concentrations in prostate tissue are dependent on the drug's lipophilicity and dosage.
  • Hydrophilic statins, specifically rosuvastatin, achieve substantially higher concentrations in prostate tissue.